Worldwide Single-use Bioprocessing Industry to 2028 - Featuring Sartorius, Eppendorf and General Electric Among Others - ResearchAndMarkets.com

The "Single-use Bioprocessing Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028" report has been added to ResearchAndMarkets.com's offering.

According to this report the global single-use bioprocessing market is anticipated to grow at a CAGR of 12.6% during the forecast period.

Company Profiles

• Meissner Filtration Products, Inc.
• Sartorius AG
• Eppendorf AG
• General Electric Company (GE Healthcare)
• Corning Incorporated
• ThermoFisher Scientific
• Rentschler Biopharma SE
• Merck KGaA
• Pall Corporation
• JM BIOCONNECT

Single-use systems (SUS) refer to biopharmaceutical manufacturing (bioprocessing) equipment that is designed for single-use and then discarded. The SUS equipment is composed of sealed plastic components that are sterilized using gamma radiation. Several advantages such as pre-sterilized equipment, avoidance of related complex steam, and avoidance of cleaning, sterilization, and validation prior usage are gaining traction towards SUS than classic stainless steel.

SUS is widely used in preclinical, clinical, biopharmaceutical manufacturing and is rapidly adopted in the manufacturing of commercial products. Single-use facilities are anticipated to dominate bioprocessing in terms of the number of facilities, bioprocessing professionals' work, and the number of products manufactured, especially at clinical scales.

Cost Reduction and Increase Productivity

The rising prevalence of chronic diseases leading to the surging demand for biologic treatment, developing research and development infrastructure, affordable disposable products, and instruments are some of the factors driving the single-use bioprocessing market. Moreover, the disposable equipment helps in plunging the costs associated with complex steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems and accessories. The growth in this market is significantly driven by the rising demand for biopharmaceuticals, as single-use bioprocessing systems play a crucial role in reducing the initial heavy investments and R&D costs involved in the manufacturing process of biologics.

Besides, in SUS, the direct cost of labor for assembly and the cost of water and chemicals are low as compared to the equivalent stainless-steel hardware systems. Also, the adoption of single-use systems surpasses the clean-in-place (CIP) and sterilize-in-place (SIP) steps, which enhance the facility utilization time and reduce the overall operating costs and analytical quality control costs, specifically for raw materials.

Added Advantages of Single-use Bioprocessing system to Benefit Biopharmaceutical Manufacturers

Based on the end-users, the single-use biopharmaceutical market has been segmented into biopharmaceutical manufacturers, academic & clinical research institutes, and others. The biopharmaceutical manufacturers segment is estimated to witness significant growth during the forecast period. The growth is attributed to various advantages over conventional bioprocessing methods. In conventional bioprocessing and manufacturing of biologics and bi-products, steel-based bioreactors are used. The components used requires sterilization for manufacturing contamination-free bioproducts, thereby increasing the overall investments for manufacturers. Whereas, a single-use bioprocessing system surpasses the sterilization step and thus reducing the additional cost of sterilization.

By the product, the market is segmented into filtration assemblies, disposables/ single-use bioreactors, media bags and containers, and others. The increasing adoption of media bags and containers in transportation and storage application is driving the media bags and containers segment.

By the application, the market is segmented into filtration, cell culture, purification, and others. The filtration segment is anticipated to witness growth in the near future owing to the popularity of single-use tangential flow filters and chromatography columns in the process development.

North America Anticipated to Grow at a Healthy Pace During the Forecast Period

North America is anticipated to witness healthy growth in the single-use bioprocessing market during the forecast period. Factors such as developed research and development infrastructure, government initiatives, the growing popularity of disposables, manufacturing at a large scale, and the presence of major players are some of the major factors impacting the single-use bioprocessing market. In addition, the robust demand for biopharmaceutical drugs from the geriatric population and patient expiries of biologics are some more factors that are also fueling the growth of the market.

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders a definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.

For more information about this report visit https://www.researchandmarkets.com/r/rtwv65

View source version on businesswire.com: https://www.businesswire.com/news/home/20220218005408/en/